Financials data is unavailable for this security.
View more
Year on year Wai Yuen Tong Medicine Holdings Ltd grew revenues 8.33% from 723.60m to 783.88m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -20.52m to -15.36m.
| Gross margin | 50.37% |
|---|---|
| Net profit margin | -0.93% |
| Operating margin | 3.14% |
| Return on assets | -0.16% |
|---|---|
| Return on equity | -1.43% |
| Return on investment | -0.25% |
More ▼
Cash flow in HKDView more
In 2024, cash reserves at Wai Yuen Tong Medicine Holdings Ltd fell by 371.73m. However, the company earned 191.69m from its operations for a Cash Flow Margin of 24.45%. In addition the company used 84.62m on investing activities and also paid 469.97m in financing cash flows.
| Cash flow per share | 0.0693 |
|---|---|
| Price/Cash flow per share | 2.68 |
| Book value per share | 1.18 |
|---|---|
| Tangible book value per share | 1.18 |
More ▼
Balance sheet in HKDView more
| Current ratio | 2.18 |
|---|---|
| Quick ratio | 1.37 |
| Total debt/total equity | 0.4038 |
|---|---|
| Total debt/total capital | 0.2879 |
More ▼
Growth rates in HKD
Year on year, growth in earnings per share excluding extraordinary items dropped -66.89%.
| Div yield(5 year avg) | 2.46% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | -- |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -78.08 |
More ▼
